KLF6 degradation after apoptotic DNA damage

被引:30
作者
Banck, Michaela S.
Beaven, Simon W.
Narla, Goutham
Walsh, Martin J.
Friedman, Scott L.
Beutler, Andreas S.
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
[4] CUNY Mt Sinai Sch Med, Div Liver Dis, New York, NY 10029 USA
关键词
Kruppel-like factor; KLF6; DNA-damage; apoptosis; chemosensitivity; proteasomal degradation; ubiquitin; cancer cells; carcinogenesis;
D O I
10.1016/j.febslet.2006.10.077
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kruppel-like factor 6 (KLF6) is a cancer gene (www.sanger.ac.uk/genetics/CGP/Census/). Here, we demonstrate that KLF6 protein is rapidly degraded when apoptosis is induced via the intrinsic pathway by cisplatin, adriamycin, or UVB irradiation in multiple cell lines (HCT116, SW40, HepG2, PO-M, Skov3, NIH-3T3, 293T, GM09706, and MEF, IMR90). KLF6 degradation occurred in the presence or absence of p53, was associated with ubiquitination, mediated by the proteasome (half-life 16 min, unstimulated), and independent of caspases and calpain. KLF6 was unchanged by apoptosis via the extrinsic/death-receptor pathway. Deregulation of KLF6 stability may alter its tumor suppressor function and/or the response of tumors to chemotherapeutics. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:6981 / 6986
页数:6
相关论文
共 26 条
  • [1] Gene-expression profiles predict survival of patients with lung adenocarcinoma
    Beer, DG
    Kardia, SLR
    Huang, CC
    Giordano, TJ
    Levin, AM
    Misek, DE
    Lin, L
    Chen, GA
    Gharib, TG
    Thomas, DG
    Lizyness, ML
    Kuick, R
    Hayasaka, S
    Taylor, JMG
    Iannettoni, MD
    Orringer, MB
    Hanash, S
    [J]. NATURE MEDICINE, 2002, 8 (08) : 816 - 824
  • [2] Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1
    Benzeno, S
    Narla, G
    Allina, J
    Cheng, GZ
    Reeves, HL
    Banck, MS
    Odin, JA
    Diehl, JA
    Germain, D
    Friedman, SL
    [J]. CANCER RESEARCH, 2004, 64 (11) : 3885 - 3891
  • [3] DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
    Bernstein, C
    Bernstein, H
    Payne, CM
    Garewal, H
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2002, 511 (02) : 145 - 178
  • [4] Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells
    Chen, CS
    Sun, XD
    Guo, P
    Dong, XY
    Sethi, P
    Cheng, XH
    Zhou, J
    Ling, JX
    Simons, JW
    Lingrel, JB
    Dong, JT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) : 41553 - 41561
  • [5] Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway
    Chen, ZY
    Wang, XS
    Zhou, YH
    Offner, G
    Tseng, CC
    [J]. CANCER RESEARCH, 2005, 65 (22) : 10394 - 10400
  • [6] Genetic alterations of the KLF6 gene in gastric cancer
    Cho, YG
    Kim, CJ
    Park, CH
    Yang, YM
    Kim, SY
    Nam, SW
    Lee, SH
    Yoo, NJ
    Lee, JY
    Park, WS
    [J]. ONCOGENE, 2005, 24 (28) : 4588 - 4590
  • [7] Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells
    Fukazawa, T
    Fujiwara, T
    Uno, F
    Teraishi, F
    Kadowaki, Y
    Itoshima, T
    Takata, Y
    Kagawa, S
    Roth, JA
    Tschopp, J
    Tanaka, N
    [J]. ONCOGENE, 2001, 20 (37) : 5225 - 5231
  • [8] Gene expression profiling predicts clinical outcome of prostate cancer
    Glinsky, GV
    Glinskii, AB
    Stephenson, AJ
    Hoffman, RM
    Gerald, WL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) : 913 - 923
  • [9] Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells
    Hata, T
    Yamamoto, H
    Ngan, CY
    Koi, M
    Takagi, A
    Damdinsuren, B
    Yasui, M
    Fujie, Y
    Matsuzaki, T
    Hemmi, H
    Xu, XD
    Kitani, K
    Seki, Y
    Takemasa, I
    Ikeda, M
    Sekimoto, M
    Matsuura, N
    Mondeni, M
    [J]. MOLECULAR CANCER THERAPEUTICS, 2005, 4 (10) : 1585 - 1594
  • [10] NF-κB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells
    Hermisson, M
    Weller, M
    [J]. CELL DEATH AND DIFFERENTIATION, 2003, 10 (09) : 1078 - 1089